Оn the sample of 90 patients with chronic heart failure at the stage of stabilization we studied the influence of concomi-tant depressive and anxiety disorders on functional ability, quality of life and adherence to therapy. In our investigation we used the integrated and interdisciplinary approach to evaluation of psychosomatic status of patients, including test six minute walk, the method of clinical-scale evaluation, and an expert evaluation by a doctor. The data were processed using the program Microsoft Office Excel 2007 statistical software package SPSS Statistics 17.0. Significant frequency of anxious, depressive and comorbid anxiety and depressive disorders, which affect compliance and aggravate the functioning of the patients, was confirmed. It is shown that the results of treatment and rehabilita-tion activities are mediated by the presence and severity of anxiety and depressive disorders.
chronic heart failure, compliance, anxiety, depression, quality of life
1. MedvedevVE, KopylovFY, TrosnovaAP, Machils-kayaOV, MartynovSE, VisurovSA (2007). Psychosomatic correlations in crisis course of essential hypertension [Psikhosomaticheskie sootnosheniya pri krizovom techenii gipertonicheskoy bolezni]. Psikhicheskie rasstroystva v obshchey meditsine, 2(1), 10-13.
2. .PetrovaNN, KutuzovaAE, BobrovskayaEE (2010). Drug correction of anxiety disorders in patients with acute myocardial infarction [Medikamentoznaya korrektsiya trevozhnykh rasstroystv u bol’nykh ostrym infarktom miokarda]. Vrach, (7), 53-56.
3. PetrovaNN, KutuzovaAE, FrolovaEV, AndryukhinAN (2010). Diagnostics and correction of affective disorders in patients with chronic heart failure in general practice [Diagnostika i korrektsiya affektivnykh rasstroystv u bol’nykh s khronicheskoy serdechnoy nedostatochnost’yu v obshchey vrachebnoy praktike. Uchebnoe posobie], 44.
4. PetrovaNN, KutuzovaAE (2014). Interdisciplinary approach to the management of patients with life-threatening medical conditions [Mezhdistsiplinarnyy podkhod k vedeniyu patsientov s zhizneopasnym somaticheskim sostoyaniem]. Obozrenie psikhiatrii i meditsinskoy psikhologii im. V.M.Bekhtereva, (1), 97-104
5. PogosovaGV (2002). Depression - a new risk factor for coronary heart disease and a predictor of coronary death [Depressiya - novyy faktor riska ishemicheskoy bolezni serdtsa i prediktor koronarnoy smerti]. Kardiologiya, (4), 86-91
6. SmulevichAB, SyrkinAL, DrobizhevMY, IvanovSV (2005). Psychocardiology [Psikhokardiologiya], 778.
7. ShlyakhtoEV, SitnikovaMY, LelyavinaTA, IvanovSG, TrukshinaMA, FedotovPA, DorofeykovVV, SmirnovBI(2009). Modern forecasting estimation algorithms in patients with chronic heart failure (CHF). Comparative characteristics of MNP - age model of survival (Neva-75) and Seattle heart failure model in patients 75-85 years old [Sravnitel’naya kharakteristika MNP - vozrastnoy modeli vyzhivaemosti (Neva-75) i Siettlskoy modeli serdechnoy nedostatochnosti (Seattle heart failure model) u bol’nykh 75-85 let]. Serdechnaya nedostatochnost’, 10(1), 4-7
8. BartJ, SchumacherM, Herrmann-LingenC (2004).Depression as a risk factor for mortality in patients with heart disease: a meta-analysis. Psychosom., (66), 802-813.
9. DhillonS, ScottLJ, PloskerGL (2006). Escitalopram: a review of its use in the management of anxiety disorders. CNS Drugs, 20(9), 763-790.
10. RudischB, NemeroffCB. (2003). Epidemiology of comorbid coronary artery disease and depression. Biol. Psychiat., 54(3), 227-240.
11. StrikJJ, LousbergaR, CheriexbEC, HonigaA (2004). One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J. Psychosomat. Res., (56), 59-66.
